An Emerging Approval Trend At FDA: More First-Time Sponsors
By
Kate Rawson / Email the Author / The RPM Report January 2012, Vol. 8, No. 2
Feature Articles / Word Count: 3377 / Article # 2012500024
Executive Summary
There is a surprising trend in the list of FDA approvals in 2011: an increase in the number of small biopharma companies opting to forgo Big Pharma partnerships and submit new product applications on their own. Here’s how these “emerging sponsors” are changing the way FDA does business—for big and small companies alike.
$125.00
Buy Now
For $125.00, purchase this 3377-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.